LF-15 & T7, synthetic peptides derived from tumstatin, attenuate aspects of airway remodelling in a murine model of chronic OVA-induced allergic airway disease

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Grafton, Karryn T ^a,b   Moir, Lyn M ^a,b   Black, Judith L ^a,b   Hansbro, Nicole G ^c   Hansbro, Philip M ^c   Burgess, Janette K ^a,b   Oliver, Brian G ^a,b  

^a WOOLCOCK INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

LF 15 PEPTIDE; OVALBUMIN; SYNTHETIC PEPTIDE; T3 PEPTIDE; T7 PEPTIDE; TUMSTATIN; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR;

AIRWAY REMODELING; AIRWAY RESISTANCE; ALLERGIC AIRWAY INFLAMMATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; CELL VIABILITY; COMBINATION CHEMOTHERAPY; DRUG PROTEIN BINDING; ENDOTHELIUM CELL; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LUNG BLOOD VESSEL; LUNG ENDOTHELIUM; LUNG MITOCHONDRION; MITOCHONDRION; MONOTHERAPY; MOUSE; NONHUMAN; PNEUMONIA; RESPIRATORY TRACT ALLERGY;

AIRWAY REMODELING; ANIMALS; ANTI-ASTHMATIC AGENTS; ASTHMA; CELL SURVIVAL; COLLAGEN TYPE IV; ENDOTHELIAL CELLS; HUMANS; LUNG; MICE; MICE, INBRED BALB C; MITOCHONDRIA; NEOVASCULARIZATION, PHYSIOLOGIC; PEPTIDE FRAGMENTS; PRIMARY CELL CULTURE;

EID: 84898670742     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0085655     Document Type: Article

References (15)

1. Shifren A, Wiit C, Christie C, Castro M (2012) Mechanisms of remodelling in asthmatic airways. J Allergy: 316049. doi:10.1155/2012/316049.
2. Li X, Wilson JW (1997) Increased vascularity of the bronchial mucosa in (Pubitemid 27293194)
3. Jackson JR, Seed MP, Kircher CH, Willoughby DA, Winkler JD (1997) The codependence of angiogenesis and chronic inflammation. FASEB J 11:457-65. Review. (Pubitemid 27259987)
4. Sont JK, Willems LN, Bel EH, Van Krieken JH, Vandenbroucke JP et al (1999) Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. Am J Respir Crit Care Med 159:1043-1051. (Pubitemid 29202534)
5. Burgess JK, Boustany S, Moir LM, Weckmann M, Lau JY et al (2010) Reduction of tumstatin in asthmatic airways contributes to angiogenesis, inflammation, and hyperresponsiveness. Am J Respir Crit Care Med 181:106-115.
6. Eikesdal HP, Sugimoto H, Birrane G, Maeshima Y, Cooke VG et al (2008) Identification of amino acids essential for the antiangiogenic activity of tumstatin and its use in combination antitumor activity. PNAS 105:15040-15045.
7. Laube BL (2001) Treating diabetes with aerosolized insulin. Chest 120:99S-106S. (Pubitemid 32881571)
8. Lee SY, Cho JY, Miller M, McElwain K, McElwain S et al (2006) Immunostimulatory DNA inhibits allergen-induced peribronchial angiogenesis in mice. J Allergy Clin Immunol 117:597-603. (Pubitemid 43340224)
9. Asosingh K, Swaidani S, Aronica M, Erzurum SC (2007) Th1- and Th2-dependent endothelial progenitor cell recruitment and angiogenic switch in asthma. J Immunol 178:6482-6494. (Pubitemid 46717432)
10. Horvat JC, Beagley KW, Wade MA, Preston JA, Hansbro NG et al (2007) Neonatal chlamydial infection induces mixed T-Cell responses that drive allergic airway disease. Am J Respir Crit Care Med 176:556-564. (Pubitemid 47403273)
11. Maeshima Y, Manfredi M, Reimer C, Holthaus KA, Hopfer H et al (2001) Identification of the anti-angiogenic site within vascular basement membranederived tumstatin. J Biol Chem 276:15240-15248.
12. Zan J, He X, Long W, Liu P (2012) Insights into binding modes of tumstatin peptide T7 with the active site of αvβ3 integrin. Molecular Simulation 38:498-508.
13. Gaggar A, Jackson PL, Noerager BD, O'Reilly PJ, McQuaid DB et al (2008) A novel proteolytic cascade generates an extracellular matrix-derived chemoattractant in chronic neutrophilic inflammation. J Immunol 180:5662-5669.
14. Herbert C, Hettiaratchi A, Webb DC, Thomas PS, Foster PS et al (2008) Suppression of cytokine expression by roflumilast and dexamethasone in a model of chronic asthma. Clin Exp Allergy 38:847-856. (Pubitemid 351550666)
15. Kumar RK, Herbert C, Foster PS (2008) The 'classical' ovalbumin challenge model of asthma in mice. Curr Drug Targets 9:485-494. (Pubitemid 352025205)